XML 76 R61.htm IDEA: XBRL DOCUMENT

Earnings per share (Tables)

12 Months Ended

Jun. 30, 2021

Text block [abstract]

Summary of earnings per share


		2021 A$’000				2020 A$’000				2019 A$’000
Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(8,422	)			(12,467	)			(10,270	)

Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(8,422	)			(12,467	)			(10,270	)


		Number				Number				Number
Weighted average number of ordinary shares used in calculating basic earnings per share			117,674,543				73,053,514				57,503,555

Weighted average number of ordinary shares used in calculating Diluted earnings per share			117,674,543				73,053,514				57,503,555


		Cents				Cents				Cents
Basic earnings per share			(7.16	)			(17.07	)			(17.86	)
Diluted earnings per share			(7.16	)			(17.07	)			(17.86	)